GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date ...

General Catalyst and Square Peg led the $150 million financing round with participation from NVentures, NVIDIA’s venture ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.

A Stanford-led study found that most AI chatbots have stopped including medical disclaimers in health responses, raising concerns that users might trust potentially unsafe or unverified advice.

This tech is intended to enable early detection of skin conditions in remote areas worldwide, without internet or direct access to medical professionals.

Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference - Avant Technologies, Inc. ("Avant" or the "Company"), an emerging technology company developing healthcare solutions ...

Singapore researchers have unveiled a powerful new AI tool that can predict whether a liver cancer patient is likely to ...

Driven by purpose and powered by partnerships, Vietnamese scientists are making their mark on global research and innovation.

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

Artificial intelligence (AI) in health care is rapidly advancing beyond traditional applications. Autonomous AI agents are ...

A researcher at a Scottish university has developed AI tools that could give people in remote areas of the world access to fast and potentially life-saving skin cancer diagnoses. Tess Watt, the PhD ...